Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin Effects on Attention and Startle in PTSD
NCT03211013Phase 1Completed
- Sponsor
- Palo Alto Veterans Institute for Research
- Start
- Jul 2017
- Primary completion
- Jun 2021
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of oxytocin nasal spray in post-traumatic stress disorder (PTSD) (2 arms), sponsored by Palo Alto Veterans Institute for Research. Primary endpoints: Change in attentional bias and Change in startle response - heart rate. Started Jul 2017; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT03211013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03211013.